California Public Employees Retirement System’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-949,278
Closed -$174M 1557
2021
Q2
$174M Buy
949,278
+429,040
+82% +$73.6M 0.13% 162
2021
Q1
$79.5M Sell
520,238
-15,465
-3% -$2.39M 0.06% 315
2020
Q4
$83.7M Buy
535,703
+28,550
+6% +$3.67M 0.06% 291
2020
Q3
$58M Buy
507,153
+18,452
+4% +$1.99M 0.05% 334
2020
Q2
$54.9M Buy
488,701
+2,781
+0.6% +$295K 0.05% 337
2020
Q1
$43.6M Sell
485,920
-34,053
-7% -$3.34M 0.05% 329
2019
Q4
$56.2M Buy
519,973
+50,118
+11% +$5.36M 0.05% 368
2019
Q3
$46M Buy
469,855
+113,287
+32% +$12.8M 0.05% 373
2019
Q2
$46.7M Buy
356,568
+2,733
+0.8% +$352K 0.06% 338
2019
Q1
$47.8M Sell
353,835
-19,077
-5% -$2.37M 0.06% 346
2018
Q4
$36.3M Sell
372,912
-67,966
-15% -$8.03M 0.05% 378
2018
Q3
$61.3M Sell
440,878
-44,149
-9% -$5.54M 0.08% 252
2018
Q2
$60.2M Sell
485,027
-41,542
-8% -$4.86M 0.08% 234
2018
Q1
$58.7M Sell
526,569
-27,473
-5% -$3.28M 0.08% 236
2017
Q4
$66.3M Buy
554,042
+90,463
+20% +$11M 0.09% 227
2017
Q3
$65M Buy
463,579
+15,588
+3% +$2.12M 0.1% 208
2017
Q2
$54.5M Buy
447,991
+9,300
+2% +$1.08M 0.09% 233
2017
Q1
$53.2M Sell
438,691
-18,300
-4% -$2.36M 0.09% 233
2016
Q4
$55.9M Sell
456,991
-31,600
-6% -$3.87M 0.09% 218
2016
Q3
$59.9M Sell
488,591
-31,800
-6% -$4.09M 0.1% 210
2016
Q2
$60.8M Sell
520,391
-23,400
-4% -$3.32M 0.1% 215
2016
Q1
$75.7M Sell
543,791
-35,100
-6% -$5.15M 0.12% 156
2015
Q4
$110M Sell
578,891
-1,700
-0.3% -$297K 0.17% 115
2015
Q3
$90.8M Buy
580,591
+13,699
+2% +$2.5M 0.15% 129
2015
Q2
$102M Sell
566,892
-48,192
-8% -$8.32M 0.15% 125
2015
Q1
$111M Hold
615,084
0.15% 133
2014
Q4
$111M Buy
615,084
+16,116
+3% +$2.99M 0.15% 133
2014
Q3
$99.3M Sell
598,968
-30,341
-5% -$4.98M 0.14% 149
2014
Q2
$98.3M Sell
629,309
-127,745
-17% -$20.2M 0.13% 156
2014
Q1
$112M Buy
757,054
+54,425
+8% +$8.65M 0.16% 125
2013
Q4
$93.4M Buy
702,629
+175,304
+33% +$21M 0.14% 146
2013
Q3
$61.3M Buy
527,325
+6,220
+1% +$682K 0.11% 169
2013
Q2
$48.1M Buy
+521,105
New +$50.2M 0.1% 208

Other funds holding ALXN